Our global strategic R&D facility, The Discovery Centre (DISC) in Cambridge, houses one of the largest and most advanced compound management and high throughput screening facilities in the world. This technology has the potential to allow us to test over one million compounds per day, significantly accelerating the early stages of the drug discovery process, with the aim to discover the next generation of medicines that have the potential to transform the lives of patients around the globe. ----------------------------------------------------------- Global site: https://learn.az/6055IevB1 Careers site: https://learn.az/6056IevBG Follow us: X: https://learn.az/6058IevBy LinkedIn: https://learn.az/6050IevBK Instagram: https://learn.az/6052IevBM Facebook: https://learn.az/6053IevB3

AZNAstraZenecaCambridgeCambridge Biomedical CampusCompound ManagementDISCDrug DiscoveryHTSHigh Throughput ScreeningPascal SoriotThe Discovery Centreastrazeneca euaz share pricezeneca